Experienced in Pleurisy

Yiqing Qu

Jinan, CN 
Experienced in Pleurisy
Jinan, CN 
OverviewLocationsClinical Research

Overview

Yiqing Qu practices in Jinan, China. Ms. Qu is rated as an Experienced expert by MediFind in the treatment of Pleurisy. Her top areas of expertise are Pleural Effusion, Sjogren Syndrome, Dry Mouth, and Dry Eye Syndrome.

Her clinical research consists of co-authoring 28 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 1 article in the study of Pleurisy.

Gender
Female

Locations

Jinan, 250012, China
Other Locations
China

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Phase III, 12 Week, Randomized, Double-blind, 4 Arm Parallel Group Bridging Study, Comparing the Efficacy, Safety and Tolerability of the Fixed Dose Combination FF/UMEC/VI Once-daily Via a Dry Powder Inhaler With Dual Combination of FF/VI, Administered in Chinese Participants With Inadequately Controlled Asthma
A Phase III, 12 Week, Randomized, Double-blind, 4 Arm Parallel Group Bridging Study, Comparing the Efficacy, Safety and Tolerability of the Fixed Dose Combination FF/UMEC/VI Once-daily Via a Dry Powder Inhaler With Dual Combination of FF/VI, Administered in Chinese Participants With Inadequately Controlled Asthma
Enrollment Status: Completed
Publish Date: August 11, 2025
Intervention Type: Device, Drug
Study Drugs: FF/VI, FF/UMEC/VI
Study Phase: Phase 3
A Randomized, Double Blind, Parallel Group Study of the Efficacy and Safety of Mepolizumab as Adjunctive Therapy in Patients With Severe Asthma With Eosinophilic Inflammation
A Randomized, Double Blind, Parallel Group Study of the Efficacy and Safety of Mepolizumab as Adjunctive Therapy in Patients With Severe Asthma With Eosinophilic Inflammation
Enrollment Status: Completed
Publish Date: September 19, 2024
Intervention Type: Drug
Study Drugs: Mepolizumab, Salbutamol
Study Phase: Phase 3
View 1 Less Clinical Trial

28 Total Publications

Sono-Immunotherapy for Lung Cancer Utilizing Targeted Preactivated Neutrophil Membrane-Coated Nanoparticles.
Sono-Immunotherapy for Lung Cancer Utilizing Targeted Preactivated Neutrophil Membrane-Coated Nanoparticles.
Journal: Bioconjugate chemistry
Published: October 27, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Qu's expertise for a condition
ConditionClose
        View All 13 Experienced Conditions
        Want to save this expert for later?
        Sign Up
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile